Femoropopliteal artery obstructions: From the balloon to the stent-graft

CardioVascular and Interventional Radiology

Volumn 24, Issue 2, 2001, Pages 73-83

  Lammer, Johannes ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; TICLOPIDINE;

BLOOD VESSEL GRAFT; BLOOD VESSEL INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STENT; STROKE; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIAL OCCLUSIVE DISEASES; FEMORAL ARTERY; HUMANS; POPLITEAL ARTERY; STENTS; TREATMENT OUTCOME;

EID: 0035014272     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002700001749     Document Type: Review

References (104)

1. Transluminal treatment of arteriosclerotic obstructions: Description of a new technique and a preliminary report of its application
2. The treatment of occlusive arterial disease by transluminal catheter angioplasty
3. Percutaneous recanalization after chronic arterial occlusions with a new dilator-catheter
4. Transluminal blood vessel dilatation by means of a modified dilatation catheter
5. The mechanism of balloon angioplasty
6. Transluminal angioplasty evaluated by electron microscopy
7. Vessel, plaque, and lumen morphology after transluminal balloon angioplasty: Quantitative study in distended human arteries
8. The vessel wall reaction in restenosis
9. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit
10. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy
11. Arterial remodelling after coronary angioplasty: A serial intravascular ultrasound study
12. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries
13. Arterial remodelling by atherosclerosis
14. Compensatory enlargement versus chronic constriction: The two features of vascular remodelling after experimental angioplasty
15. Expandable intraluminal graft: A preliminary study
16. Intravascular stents: Tissue-stent interactions and design considerations
17. Histopathology of in-stent restenosis in patients with peripheral artery disease
18. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries
19. Relationship between blood flow, thrombus, and neointima in stents
20. Mechanisms of arterial graft failure. II. Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses
21. Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity
22. Patency and tissue response related to two types of polytetrafluoroethylene-covered stents in the dog
23. Biocompatibility and performance of different types of covered stents in the sheep model
24. Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries
25. Human transluminally placed endovascular stented grafts: Preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease
26. Effect of polytetrafluoroethylene covering of Palmaz stents on the development of intimal hyperplasia in human iliac arteries
27. Die chirurgische behandlung der peripheren durchblutungsstörung
28. Recommended standards for reports dealing with lower extremity ischemia: Revised version
29. Secondary prevention of vascular disease by prolonged antiplatelet treatment
30. Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians Health Study
31. Prevention of myocardial infarction and stroke in patients with intermittent claudication: Effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicenter Study
32. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)
33. Hospital vs home based exercise rehabilitation for patients with peripheral arterial occlusive disease
34. Benefit of exercise conditioning for patients with peripheral arterial disease
35. Superiority of treadmill walking exercise vs strength training for patients with peripheral arterial disease
36. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomized trial
37. Exercise rehabilitation programs for the treatment of claudication pain: A meta-analysis
38. Value of a supervised exercise program for the therapy of arterial claudication
39. Arteriographic complications in the DSA era
40. Impact of ultrasonographic duplex scanning on therapeutic decision making in lower-limb arterial disease
41. The use of color-coded duplex scanning in the selection of patients with lower extremity arterial disease for percutaneous transluminal angioplasty: A prospective study
42. Can duplex scanning replace arteriography for lower extremity arterial disease?
43. The potential for duplex scanning to replace aorto-iliac and femoral popliteal arteriography
44. Evaluation of the aortoiliac and renal arteries: Comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography
45. Iliac artery stenosis measurements: Comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography
46. Peripheral vascular tree stenoses: Evaluation with moving-bed infusion-tracking MR angiography
47. Magnetic resonance angiography in the management of lower extremity arterial occlusive disease: A prospective study
48. Aortic and lower-extremity arterial disease: Evaluation with MR angiography versus conventional angiography
49. Use of magnetic resonance angiography for the preoperative evaluation of patients with infrainguinal arterial occlusive disease
50. MR angiography in the evaluation of atherosclerotic peripheral vascular disease
51. Utility of magnetic resonance arteriography for distal lower extremity revascularization
52. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial
53. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels
54. Angioplasty standard of practice
55. TransAtlantic InterSociety Consensus (TASC) document on management of peripheral arterial disease
56. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection
57. Subintimal angioplasty of femoropopliteal artery occlusions: The long-term results
58. Percutaneous vascular interventions: Value of hemodynamic measurements
59. Restenosis of endovascular stents from stent compression
60. Peripheral arterial obstruction: Prospective study of a treatment with transluminally placed self-expanding stent-graft
61. Complications of transluminal angioplasty
62. Suture-mediated percutaneous closure of antegrade femoral arterial access sites in patients who have received full anticoagulation therapy
63. Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA
64. Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease: A prospective double-blind trial
65. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty
66. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit
67. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators
68. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation
69. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation
70. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: Results from non-invasive testing of a defined population
71. Ankle-arm blood pressure index: A useful test for clinical practice?
72. The MOS 36-item short form health survey (SF36): Conceptual framework and item selection
73. Percutaneous transluminal angioplasty of the arteries of the lower limbs: A 5 year follow-up
74. Percutaneous transluminal angioplasty of the femoropopliteal artery: Initial and long term results
75. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia
76. Femoropopliteal angioplasty: Factors influencing long-term success
77. Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty
78. Revascularization of femoropopliteal artery disease: A decision and cost effective analysis
79. Femoropopliteal angioplasty in patients with claudication: Primary and secondary patency in 140 limbs with 1-3 year follow-up
80. Long-segment (≥10 cm) femoropopliteal angioplasty: Improved techical success and long-term patency
81. Pulsed excimer laser versus continuous-wave Nd:YAG laser versus conventional angioplasty of peripheral arterial occlusions: Prospective, controlled, randomized trial
82. Treatment of femoropopliteal stenoses by means of self-expandable endoprostheses: Midterm results
83. Arterial stent placement with use of the Wallstent: Midterm results of clinical experience
84. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions
85. Femoropopliteal stent placement: Long-term results
86. The Strecker stent: Indications and results in iliac and femoropopliteal arteries
87. Palmaz stent placement in iliac and femoropopliteal arteries: Primary and secondary patency in 310 patients with 2-4 year follow-up
88. Multicenter trial of the Wallstent in iliac and femoral arteries
89. Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation
90. Strecker stents in the femoropopliteal arteries: Value of duplex ultrasonography in restenosis assessment
91. Femoropopliteal artery stent placement: Evaluation of long-term success
92. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty
93. Long-term results with the Palmaz stent in the superficial femoral artery
94. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study
95. Percutaneous transluminal angioplasty (PTA) versus Palmaz stent placement in femoropopliteal artery obstruction: A multicenter prospective randomized study
96. Percutaneous femoropopliteal graft placement
97. Treatment of peripheral vascular disease with stent-grafts
98. Occlusive and aneurysmal peripheral arterial disease: Assessment of a stent-graft system
99. Perivascular inflammatory reaction after percutaneous placement of covered stents
100. Cragg Endopro-I: Early experience in femoral arteries
101. Incidence of pseudoaneurysm after diagnostic and therapeutic angiography
102. Noncoronary angioplasty
103. Complications of lower limb percutaneous transluminal angioplasty: A prospective analysis of 410 procedures on 295 consecutive patients
104. Femoropopliteal angioplasty for severe limb ischemia